Want to see IN:ZYDUSWELL full AI Analyst Report?
ZYDUSWELL Stock Chart & Stats
₹424.90
-₹21.60(-1.10%)
At close: 4:00 PM EST
₹424.90
-₹21.60(-1.10%)
Day’s Range― - ―
52-Week Range₹357.55 - ₹610.95
Previous CloseN/A
Volume6.77K
Average Volume (3M)33.88K
Market Cap
₹156.42B
Enterprise Value₹166.44B
Total Cash (Recent Filing)₹1.15B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)83.1
Beta0.92
Next Earnings
Nov 14, 2026EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)5.92
Shares Outstanding318,160,700
10 Day Avg. Volume10,469
30 Day Avg. Volume33,882
Financial Highlights & Ratios
PEG Ratio-1.59
Price to Book (P/B)2.33
Price to Sales (P/S)3.42
P/FCF Ratio345.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.46
Revenue Forecast (FY)₹53.22B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe sharp FY2026 acceleration shows strong demand and improved market traction across the business. If sustained, higher sales can expand distribution scale, support brand investment, and create a stronger base for recovering profitability over the next several quarters.
Established Brand And Distribution PlatformEstablished brands and broad channel access provide a durable platform for repeat purchases and product extensions in health and wellness. Coverage across general trade and modern retail can support nationwide reach, improve launch effectiveness, and reinforce competitive positioning.
Positive Free Cash FlowDespite a substantial year-on-year decline, the company still generated positive free cash flow in FY2026. Continued cash generation provides some internal funding for operations and brand investment, while preserving a foundation for rebuilding stronger cash conversion as performance stabilizes.
Bears Say
Sharp Margin CompressionThe sharp decline in net and EBIT margins indicates that strong sales growth is not currently translating proportionately into earnings. Persistent cost, pricing, or mix pressure would reduce reinvestment capacity and make future profit growth less dependable.
Higher LeverageThe substantial increase in leverage reduces financial flexibility compared with the company’s previously lightly indebted position. Higher debt can constrain capital allocation, increase financing sensitivity, and leave fewer balance-sheet resources available to absorb operating volatility.
Weaker Cash ConversionThe steep decline in operating and free cash flow shows that reported earnings converted less effectively into cash. Weaker conversion can limit self-funded growth, increase reliance on financing, and signal that working-capital or cash-cost pressure may persist beyond the latest reporting period.
Zydus Wellness Limited News
ZYDUSWELL FAQ
What was Zydus Wellness Limited’s price range in the past 12 months?
Zydus Wellness Limited lowest stock price was ₹357.55 and its highest was ₹610.95 in the past 12 months.
What is Zydus Wellness Limited’s market cap?
Zydus Wellness Limited’s market cap is ₹156.42B.
When is Zydus Wellness Limited’s upcoming earnings report date?
Zydus Wellness Limited’s upcoming earnings report date is Nov 14, 2026 which is in 32 days.
How were Zydus Wellness Limited’s earnings last quarter?
Zydus Wellness Limited released its earnings results on Aug 04, 2026. The company reported ₹3.7 earnings per share for the quarter, missing the consensus estimate of ₹3.933 by -₹0.233.
Is Zydus Wellness Limited overvalued?
According to Wall Street analysts Zydus Wellness Limited’s price is currently Overvalued.
Does Zydus Wellness Limited pay dividends?
Zydus Wellness Limited pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.24%. See more information on Zydus Wellness Limited dividends here
What is Zydus Wellness Limited’s EPS estimate?
Zydus Wellness Limited’s EPS estimate is 0.27.
How many shares outstanding does Zydus Wellness Limited have?
Zydus Wellness Limited has 318,160,700 shares outstanding.
What happened to Zydus Wellness Limited’s price movement after its last earnings report?
Zydus Wellness Limited reported an EPS of ₹3.7 in its last earnings report, missing expectations of ₹3.933. Following the earnings report the stock price went down -1.894%.
Which hedge fund is a major shareholder of Zydus Wellness Limited?
Currently, no hedge funds are holding shares in IN:ZYDUSWELL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zydus Wellness Limited
Zydus Wellness Limited is an Indian firm dedicated to the creation, manufacturing, promotion, and distribution of health and wellness products. Their extensive product range encompasses popular sugar substitutes such as Sugar Free Gold, Sugar Free Natura, and Sugar Free Green. The company also offers well-known beverages like Complan, a milk-based health drink, and Glucon D, a glucose-infused refreshment, alongside Sugarlite, a unique blend of sugar and stevia. In the personal care segment, Zydus Wellness markets the Everyuth brand, featuring skincare items such as soap-free face washes, masks, scrubs, and cleansers. The Nycil brand provides solutions for prickly heat, cooling powders, and hand sanitizers. Furthermore, their Nutralite line includes a diverse array of spreads, from probiotic butter and table spreads to ghee, butter, cholesterol-fat-free spreads, mayonnaise, and chocolate spreads. Beyond its domestic operations in India, Zydus Wellness actively exports its offerings. Tracing its origins to 1988, the Ahmedabad, India-based entity was initially known as Carnation Nutra Analogue Foods Limited before adopting its current name, Zydus Wellness Limited, in January 2009. It operates as a subsidiary of Cadila Healthcare Limited.
Technical Analysis
Adani Wilmar Limited
―
Britannia Industries Ltd
―
Nestle India Ltd.
―
Patanjali Foods Limited
―
Tata Consumer Products Limited
―








